These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2690611)

  • 1. Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment.
    Laragh JH
    Am J Med; 1989 Dec; 87(6B):2S-14S. PubMed ID: 2690611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship.
    Sealey JE; Blumenfeld JD; Bell GM; Pecker MS; Sommers SC; Laragh JH
    J Hypertens; 1988 Oct; 6(10):763-77. PubMed ID: 3058795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant nephron function. A pathogenic factor in hypertension and its vascular complications of stroke and heart attack.
    Laragh JH
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):2S-6S. PubMed ID: 2009143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
    Laragh JH
    Hypertension; 1992 Sep; 20(3):267-79. PubMed ID: 1516945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renovascular hypertension: etiology and pathophysiology.
    Pickering TG
    Semin Nucl Med; 1989 Apr; 19(2):79-88. PubMed ID: 2652313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
    Hall JE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):523S-533S. PubMed ID: 1741989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.
    Romero JC; Ruilope LM; Bentley MD; Fiksen-Olsen MJ; Lahera V; Vidal MJ
    Am J Cardiol; 1988 Oct; 62(11):59G-68G. PubMed ID: 3051997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephron responses to converting enzyme inhibition in non-clipped kidney of Goldblatt hypertensive rat at normotensive pressures.
    Huang WC; Jackson CA; Navar LG
    Kidney Int; 1985 Aug; 28(2):128-34. PubMed ID: 3009954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renaissance of the renin-angiotensin system in the pathogenesis and therapy of arterial hypertension].
    Horký K
    Cas Lek Cesk; 1989 Sep; 128(37):1161-5. PubMed ID: 2805032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system. Normal physiology and changes in older hypertensives.
    Hall JE; Coleman TG; Guyton AC
    J Am Geriatr Soc; 1989 Aug; 37(8):801-13. PubMed ID: 2666488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system, the kidney, and hypertension.
    Rosenfeld JB; Zabludowski J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S22-6. PubMed ID: 2474096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of kidney in hypertension.
    Tripathi S; Tripathi K
    J Indian Med Assoc; 2003 Apr; 101(4):260-2, 264-5. PubMed ID: 12964647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of blood pressure by the renin-angiotensin-aldosterone system.
    Hall JE
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV6-21; discussion IV51-5. PubMed ID: 1893644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
    Laragh JH; Sealey JE
    Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renin-angiotensin system in the regulation of glomerular filtration.
    Sraer JD; Kanfer A; Rondeau E; Lacave R
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S21-5. PubMed ID: 2483424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
    Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.